- Stifel reiterates a Buy recommendation on shares of Align Technology (ALGN).
- The call comes on the heels of two lunches held to "gather feedback from both high volume Invisalign Teen users as well as Orthodontists that are a bit more measured with their use."
- Ultimately, Stifel says the product's traction should continue thanks to "an expanded product portfolio, a larger sales force, and an overall better macro environment."
- Analyst Jonathan Block notes that by contrast, most Street models call for "a deceleration in case volume growth in 2014 and 2015."
- Price target is $60.